Preoperative evaluation of CCND1 gene expression in ovarian cancer patients may benefit the assessment of risk and prognosis, provide a new basis for CCND1 gene as a novel target for tumor therapy, and also pave the way for clinical treatment. The gene discussed is CCND1; the disease is ovarian carcinoma.